Marek Pásek

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Hidradenitis Suppurativa

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marek Pásek, Emanuel Marques, Jiří Švec, Petr Arenberger, Monika Arenbergerova
Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International journal of dermatology (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Marek Pásek, Jindřich Kopecký, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerova
Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Marek Pásek, Emanuel Marques, Jiří Švec, Petr Arenberger, Monika Arenbergerova
Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International journal of dermatology 63 (9) (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Jindřich Kopecký, Marek Pásek, Radek Lakomy, Bohuslav Melichar, Ivona Mrazová, Ondřej Kubeček, Monika Arenbergerova, Radmila Lemstrová, Alžběta Švancarová, Vojtěch Tretera, Alžběta Hlodáková, Kamila Žváčková
The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting. Cancer medicine 13 (5) (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)